INDO-MIM is committed to the cause of helping poor people and in order to help the society at large, the company has fully funded the establishment of a new block named as “THE CHIVUKULA WING “comprising of a laboratory (except the collection area), the Blood Bank, the Cardiac Catheterization Lab (Cath. Lab), the Cardiac Care Unit, and 20 Private Rooms at the Bangalore Baptist Hospital which was inaugurated by Former President Dr. A.P.J Abdul Kalam in January 2008. Dr. Chivukula donated $ 1 million for the noble cause providing state of the art facilities, with the intention of providing health care to the marginalized people at low cost and concessional/ free care to those who cannot afford it.

With personal involvement from Dr. Chivukula, the planning and the construction of the wing took 18 months to get solemnized. Built at an area of 21, 438.5 sq. ft., this wing has an elaborate laboratory services with a new virology facility. New tests have been introduced in Immunology (Hormone Panel), Serology (Infectious disease (e.g. Torch panel) and automation has been brought in Histopathology and Hematology. A part of the Reproductive Medicine Unit has also been added to the facilities on this floor since 2011.

At the same time, superior cardiology services are also being provided to the patients who are in need, along with Orthopedic and Opthalmic theatre complex which has been set up for providing effective surgeries in a highly sterile environment. Frozen Section in Histopathology and a TB Culture Lab are due to start this year, but the Blood Bank has already started Component Separation since 2010. The increase in private rooms has also helped to admit a large number of paying patients which has in turn helped in subsidizing the poor patient care.

While the wing is used by the hospital for the benefit of the society, the company has also established a fund at the hospital and makes monthly contribution to the fund taking care of the medical needs of very poor patients; which is entirely administered by the management of the Bangalore Baptist Hospital. The satisfaction amongst the poor families is an immense pleasure to the company.

bap_1
baptist_dr_naveenthomas
“It is with grateful hearts that we look back at the past 10 years of growth of Bangalore Baptist Hospital (BBH). Mr. Krishna Chivukula had a major role in the growth story of the hospital. It was in 2006 that through a generous donation from Indo-MIMS that we were enabled to build the Chivukula Wing. This event was the first in a series of steps which paved the way for the rapid growth of the hospital. The Chivukula Wing houses the newly expanded NABL Accredited Laboratory and the Coronary Care Unit with its modern Cardiac Catheterization Lab. The Chivukula Wing was inaugurated by the Former President of India, Dr. Abdul Kallam on 18th January 2008.

Mr. Chivukula has continued to donate towards the poor patient care fund. The health needs of the students of Government Primary School, Hebbal, have been looked after using this fund. A significant number of other deserving patients are also helped through this initiative. In addition to financial involvement, Mr. Chivukula has also been a good friend, advisor and encourager in our journey of growth and the path of ‘clinical excellence’. Thank you Indo-MIMS for partnering with us!”

Dr. Naveen Thomas, Director (CEO) Bangalore Baptist Hospital

By |2025-03-15T10:14:42+05:30January 26, 2008|CSR, Social Responsibility|Comments Off on Baptist Hospital

Share This Story, Choose Your Platform!

FacebookXRedditLinkedInWhatsAppTumblrPinterestVkXingEmail

Related Posts

Sevalaya Charitable Trust
Sevalaya Charitable Trust
Gallery

Sevalaya Charitable Trust

Navajeevan
Navajeevan
Gallery

Navajeevan

Shankara Eye Foundation
Shankara Eye Foundation
Gallery

Shankara Eye Foundation

Akshayapatra
Akshayapatra
Gallery

Akshayapatra

Indo-MIM致力于帮助穷人，为了帮助整个社会，该公司完全资助建立一个名为“THE CHIVUKULA WING”的新区块，包括一个实验室（收集区除外） ，班加罗尔浸信会医院的血库，心脏导管实验室（Cath.Lab），心脏病护理室和20间私人房间，由前总统APJ Abdul Kalam博士于2008年1月开幕.Chivukula博士捐赠1美元百万美元用于提供最先进设施的崇高事业，旨在以低成本为边缘化人群提供医疗保健，并为无力支付的人提供优惠/免费护理。

在Chivukula博士的亲自参与下，机翼的规划和建设需要18个月的时间才能举行。该机翼建筑面积为21,438.5平方英尺，拥有精心设计的实验室服务和新的病毒学设施。免疫学（激素小组），血清学（传染病（例如火炬小组））引入了新的测试，自组织病理学和血液学也引入了自动化。自2011年以来，生殖医学科的一部分也被添加到该楼的设施中。 。

同时，还向需要的患者提供优质的心脏病学服务，以及为在高度无菌环境中提供有效手术而设立的整形外科和眼科剧院综合体。组织病理学和结核病文化实验室的冰冻部分将于今年开始，但血库自2010年起已开始进行组分分离。私人房间的增加也有助于招纳大量付费患者，这些患者反过来又帮助了补贴不良的病人护理。

虽然医院使用机翼以造福社会，但该公司还在医院设立了一个基金，每月向该基金捐款，以照顾非常贫困患者的医疗需求;这完全由班加罗尔浸信会医院管理。贫困家庭的满意度对公司来说是一种巨大的乐趣。

baptist_dr_naveenthomas
“我们怀着感恩的心情回顾班加罗尔浸信会医院（BBH）过去十年的发展。 Krishna Chivukula先生在医院的成长故事中发挥了重要作用。在2006年，通过Indo-MIMS的慷慨捐赠，我们得以建立Chivukula翼。这一事件是一系列步骤中的第一个，为医院的快速发展铺平了道路。 Chivukula Wing拥有新扩建的NABL认证实验室和冠状动脉监护室及其现代心导管实验室。 Chivukula Wing于2008年1月18日由印度前总统Abdul Kallam博士宣誓就职。

Chivukula先生继续向贫困的病人护理基金捐款。政府小学Hebbal的学生的健康需求得到了照顾。通过这一举措，还有大量其他应得的患者得到了帮助。除了经济参与，Chivukula先生还是我们成长之旅和“临床卓越”之路上的好朋友，顾问和鼓励者。感谢Indo-MIMS与我们合作！“

Dr. Naveen Thomas, Director (CEO) Bangalore Baptist Hospital
By |2008-01-26T09:00:15+05:30January 26, 2008|Uncategorized|Comments Off on Baptist Hospital

Share This Story, Choose Your Platform!

FacebookXRedditLinkedInWhatsAppTumblrPinterestVkXingEmail

Related Posts

DRHP-AV

DRHP-AV

Corporate Governance Policies

Corporate Governance Policies

Offer Documents

Offer Documents

Appointment Letters

Appointment Letters

white logo

SERVICES

SECTORS WE SERVE

COMPANY INFORMATION

Copyright @ 2024 INDO-MIM | All Rights Reserved

Disclaimer

 NOT FOR ACCESS IN OR BY, OR DISTRIBUTION OR TRANSMISSION IN, INTO OR TO, DIRECTLY OR INDIRECTLY, THE UNITED STATES OF AMERICA (INCLUDING ITS TERRITORIES AND POSSESSIONS), ANY STATE OF THE UNITED STATES AND THE DISTRICT OF COLUMBIA (THE “UNITED STATES”) OR ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DO SO.

THESE MATERIALS ARE NOT DIRECTED AT OR INTENDED TO BE ACCESSED BY PERSONS LOCATED OUTSIDE INDIA.

IMPORTANT: You must read and agree with the terms and conditions of the following disclaimer before continuing.

The following disclaimer applies to the draft red herring prospectus of INDO-MIM Limited (the “Company”) dated September 26, 2025 (the “Draft Red Herring Prospectus”) filed with the Securities and Exchange Board of India (“SEBI”), and BSE Limited (the “BSE”) and National Stock Exchange of India Limited (the “NSE” and together with BSE , the “Stock Exchanges”), as well as the audio visual film of the Company dated October 06th , 2025 (the “IPO AV”), each in relation to the initial public offering of the equity shares of face value of ₹ 1 each (“Equity Shares”) of the Company (“Offer”). You are advised to read the following notice carefully before accessing the Draft Red Herring Prospectus. In accessing the Draft Red Herring Prospectus, you agree to be bound by the following terms and conditions, including any modifications to them from time to time.

THE DRAFT RED HERRING PROSPECTUS IS BEING MADE AVAILABLE ON THIS WEBSITE IN ELECTRONIC FORM SOLELY TO COMPLY WITH THE SECURITIES AND EXCHANGE BOARD OF INDIA (ISSUE OF CAPITAL AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2018, AS AMENDED (“SEBI ICDR REGULATIONS”). THE IPO AV IS BEING MADE AVAILABLE ON THIS WEBSITE IN ACCORDANCE WITH MASTER CIRCULAR BEARING REFERENCE SEBI/HO/CFD/PoD-1/P/CIR/2024/0154 DATED NOVEMBER 11, 2024, ISSUED BY THE SECURITIES AND EXCHANGE BOARD OF INDIA. The Draft Red Herring Prospectus has been hosted on this website as prescribed under Regulation 26 of the SEBI ICDR Regulations. You are advised to read this disclaimer carefully before reading, accessing or making any other use of the DRHP and the IPO AV. In accessing the Draft Red Herring Prospectus and IPO AV, you agree to be bound by the following terms and conditions, including any modifications to them from time to time.

The Draft Red Herring Prospectus is directed at, and is intended for distribution to, and use by, residents of India only. Residents of countries other than India are not authorized to view or use the information in this portion of the website. The information in this portion of the website, including the Draft Red Herring Prospectus, is not intended for, and may not be accessed in or by, or distributed or transmitted in, into or to, directly or indirectly, the United States of America (including its territories and possessions), any state of the United States and the District of Columbia (the “United States”) or any other jurisdiction where it is unlawful to do so. The contents of the Draft Red Herring Prospectus is for your information only, and you acknowledge that access to the Draft Red Herring Prospectus is intended for use by you only and you agree not to forward the Draft Red Herring Prospectus on to any other person, internal or external to your company, in whole or in part, or otherwise provide access via e-mail or otherwise to any person. All persons residing outside of the United States who wish to access the Draft Red Herring Prospectus contained on the following page of this website should first ensure that they are not subject to local laws or regulations that prohibit or restrict their right to access this website or require registration or approval for any acquisition of securities by them. No part of the contents of the Draft Red Herring Prospectus shall be copied or duplicated in any form by any means or redistributed.

The Draft Red Herring Prospectus and the IPO AV do not constitute an offer to sell, or the solicitation of an offer to purchase or acquire, any securities of the Company in the United States or in any other jurisdiction in which such offer or solicitation would be unlawful prior to registration or qualification under the securities laws of such jurisdiction.

The Equity Shares have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act” ) or any other applicable law of the United States and may not be offered or sold within the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the U.S. Securities Act and applicable United States state securities laws. Accordingly, the Equity Shares are being offered and sold only (i) within India, to Indian institutional, non-institutional and retail investors in compliance with the SEBI ICDR Regulations, and (ii) outside the United States to eligible investors in “offshore transactions” as defined in, and in reliance on, Regulation S (“Regulation S”) under the U.S. Securities Act and the applicable laws of the jurisdiction where those offers and sales occur. No public offering of the Equity Shares or other securities is being made in the United States.

The Draft Red Herring Prospectus and the IPO AV or any information contained on this website or in the Draft Red Herring Prospectus and the IPO AV does not constitute, and should not be construed as, “general solicitation” or “general advertising” as defined under Regulation D of the U.S. Securities Act, or “directed selling efforts” under Regulation S.

The Company, and HDFC Bank Limited, Axis Capital Limited, ICICI Securities Limited, Kotak Mahindra Capital Company Limited and SBI Capital Markets Limited (collectively, the “Book Running Lead Managers”) and their respective affiliates, directors, officers, agents, representatives, advisers and employees do not accept any liability whatsoever, direct or indirect, that may arise from the use of the information contained on this website. The information in the Draft Red Herring Prospectus and the IPO AV is as of the date thereof and neither the Company, Promoters, the Book Running Lead Managers nor their respective affiliates, directors, officers, agents, representatives, advisers or employees are under any obligation to update or revise the Draft Red Herring Prospectus and the IPO AV to reflect circumstances arising after the date thereof. You are reminded that documents transmitted in electronic form may be altered or changed during the process of transmission and consequently, neither the Company, the Book Running Lead Managers nor any of their respective affiliates, directors, officers, agents, representatives, advisers or employees accepts any liability or responsibility whatsoever in respect of alterations or changes which have taken place during the course of transmission of the Draft Red Herring Prospectus and the IPO AV in electronic format.

Investors are advised not to rely on any other document, content or information provided in respect to the Offer on the internet/ online websites/ social media platforms/ micro-blogging platforms and by influencers/finfluencers since the same is not authorized/ approved/ commissioned/ paid by the Company or its Promoter/Directors/KMPs or SMPs in any manner. Any such posts, including on social media platforms, may be illegal in certain jurisdictions and only certain categories of persons may be authorized to access such information. Such posts, including on social media platforms, do not constitute an offer or solicitation of an offer, or any advice or recommendation to purchase, sell or transact in any of the Company’s securities.

Any potential investor should note that investment in equity shares involves a high degree of risk and for details relating to such risks, see the section titled “Risk Factors” of the red herring prospectus (“Red Herring Prospectus”). Potential investors should refer to the Red Herring Prospectus which will be filed with the Registrar of Companies, Karnataka at Bengaluru (“RoC”) and SEBI in the future, including the section titled “Risk Factors”. As there may be material changes in the Draft Red Herring Prospectus versus the Red Herring Prospectus, potential investors should not rely on the Draft Red Herring Prospectus. Similarly, IPO AV provides only the salient features of the Offer and accordingly, potential investors should not rely on the IPO AV. Any decision on whether to invest in the equity shares must be made solely on the basis of the Red Herring Prospectus and the price band advertisement.

Investors are advised not to rely on any other document, content or information provided on the Offer on the internet / online websites / social media platforms / micro-blogging platforms and by the influencers since the same is not approved / commissioned / paid by the Company or its promoter(s) / directors / KMPs in any manner.

You are accessing this website at your own risk and it is your responsibility to take precautions to ensure that it is free from viruses. Neither the Company, Promoters, the Book Running Lead Managers nor their respective affiliates, directors, officers, agents, representatives, advisers or employees will be liable or have any responsibility of any kind for any loss or damage that you incur in the event of any failure or disruption of this website, or resulting from the act or omission of any other party involved in making this website or the data contained therein available to you, or from any other cause relating to your access to, inability to access, or use of this website or the Draft Red Herring Prospectus or the IPO AV.

Failure to comply with this disclaimer may result in a violation of the applicable laws of India and other jurisdictions. Any other information contained in, or that can be accessed via this website does not constitute a part of the Draft Red Herring Prospectus and the IPO AV.

IF YOU ARE NOT PERMITTED TO VIEW THE MATERIALS ON THIS WEBSITE OR ARE IN ANY DOUBT AS TO WHETHER YOU ARE PERMITTED TO VIEW THESE MATERIALS, PLEASE EXIT THIS WEBPAGE.

To access this information, you must confirm, by pressing on the button marked “I Confirm”, that at the time of accessing this information, you are located in India. If you cannot make this confirmation, you must press the button marked “I Do Not Confirm”.

The documentation contained in these pages is posted solely to comply with Indian legal and regulatory requirements. Making the information contained herein available in electronic format does not constitute an offer to sell, the solicitation of an offer to buy, or a recommendation to buy or sell securities of the Company in the United States or in any other jurisdiction, including without limitation, India.

DISCLAIMER – IMPORTANT

PLEASE READ THIS NOTICE CAREFULLY. IT APPLIES TO ALL PERSONS WHO VIEW THIS WEBSITE. THESE MATERIALS ARE NOT DIRECTED AT OR INTENDED TO BE ACCESSED BY PERSONS LOCATED OUTSIDE INDIA. VIEWING THIS INFORMATION MAY NOT BE LAWFUL IN CERTAIN JURISDICTIONS.

YOU SHOULD READ IT IN FULL EACH TIME YOU VISIT THE WEBSITE. BY ACCESSING THIS INFORMATION ON THIS WEBSITE, YOU AGREE TO THE TERMS AND CONDITIONS BELOW, INCLUDING ANY MODIFICATIONS THAT MAY BE MADE TO THEM FROM TIME TO TIME

THE DRAFT RED HERRING PROSPECTUS HAS BEEN MADE AVAILABLE ON OUR WEBSITE TO COMPLY WITH THE SECURITIES AND EXCHANGE BOARD OF INDIA (ISSUE OF CAPITAL AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2018, AS AMENDED.

IMPORTANT: You must read and agree with the terms and conditions of the following disclaimer before continuing.

The following disclaimer applies to the draft red herring prospectus of INDO-MIM Limited (the “Company”) dated September 26, 2025 (the “Draft Red Herring Prospectus”) filed with the Securities and Exchange Board of India (“SEBI”), BSE Limited, and the National Stock Exchange of India Limited and hosted on this website in connection with the initial public offering of the equity shares of the Company (the “Offer”).

Access to the Draft Red Herring Prospectus does not constitute a recommendation by the Company, the members of the Syndicate (as defined in the Draft Red Herring Prospectus) or any of their respective affiliates or any other person to subscribe to the Equity Shares offered in the Offer.

The Draft Red Herring Prospectus is directed at, and is intended for distribution to, and use by, residents of India only. The information in this portion of our website, including the Draft Red Herring Prospectus, is not for publication or distribution, directly or indirectly, in or into the United States. No part of the contents of the Draft Red Herring Prospectus shall be copied or duplicated in any form by any means or redistributed.

The Draft Red Herring Prospectus has been hosted on this website as prescribed under Regulation 26(1) of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended. Our Company has taken all necessary steps to ensure that the contents of the Draft Red Herring Prospectus as appearing on this website are identical to the Draft Red Herring Prospectus filed with the SEBI, BSE Limited, and the National Stock Exchange of India Limited. You are reminded that documents transmitted in electronic form may be altered or changed during the process of transmission and consequently, neither the Company nor any of its affiliates, directors, agents, officers, representatives, advisers or employees accepts any liability or responsibility whatsoever in respect of alterations or changes which have taken place during the course of transmission of electronic data.

The Draft Red Herring Prospectus does not constitute an offer to sell or an invitation to subscribe to the securities offered in any jurisdiction to any person to whom it is unlawful to make an offer or invitation in such jurisdiction and is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where (a) distribution or use of such information would be contrary to law or regulation; or (b) the Company or any of its affiliates would by virtue of such distribution become subject to new or additional registration, licensing or other regulatory requirements. The securities described in the Draft Red Herring Prospectus have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any other applicable law of the United States and, unless so registered, may not be offered or sold within the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the U.S. Securities Act and applicable state securities laws. Accordingly, the securities described in the Draft Red Herring Prospectus are being offered and sold (a) in the United States only to persons reasonably believed to be “qualified institutional buyers” (as defined in Rule 144A under the U.S. Securities Act) pursuant to the private placement exemption set out in Section 4(a) of the U.S. Securities Act, and (b) outside the United States in “offshore transactions” as defined in and in compliance with Regulation S under the U.S. Securities Act and the applicable laws of the jurisdictions where those offers and sales are made. For the avoidance of doubt, the term “U.S. QIBs” does not refer to a category of institutional investors defined under applicable Indian regulations and referred to in this Draft Red Herring Prospectus as “QIBs”. There will be no public offering of such securities in the United States.

Any person into whose possession the Draft Red Herring Prospectus comes is required to inform himself or herself about and to observe any such restrictions. Neither the Company nor any of its affiliates is soliciting any action based on the Draft Red Herring Prospectus, and it should not be construed as an offer to sell or the solicitation of an offer to buy any securities. Potential investors should not rely on the Draft Red Herring Prospectus for any investment decision.

Any decision on whether to invest in the securities described in the Draft Red Herring Prospectus may only be made after a Red Herring Prospectus has been filed with the Registrar of Companies, Karnataka at Bengaluru and the SEBI and must be made solely on the basis of such Red Herring Prospectus, as there may be material changes in the Red Herring Prospectus compared to the Draft Red Herring Prospectus. Invitations to subscribe to or purchase the equity shares in the Offer will be made only pursuant to the Red Herring Prospectus if the recipient is in India or the preliminary offering memorandum for the Offer, which comprises the Red Herring Prospectus and the preliminary international wrap for the Offer, if the recipient is outside India. No person outside India is eligible to Bid for equity shares in the Offer unless that person has received the preliminary offering memorandum for the Offer, which shall contain the selling restrictions for the Offer outside India.

Any potential investor should note that investment in equity shares involves a high degree of risk and for details relating to such risk, please see the section titled “Risk Factors” of the Draft Red Herring Prospectus. The Offer shall be made only pursuant to the Red Herring Prospectus, when available. Potential investors should also refer to the Red Herring Prospectus which will be filed with the Registrar of Companies, Karnataka at Bengaluru, and SEBI in the future, including the section titled “Risk Factors.”

Neither the Company nor any of its affiliates, directors, agents, officers, representatives, advisers, or employees will be responsible for any loss or damage that could result from interception and interpretation by any third parties of any information being made available to you through this website. The Company and its affiliates cannot and do not guarantee the accuracy, timeliness or completeness of the information being made available to you in the Draft Red Herring Prospectus beyond the date of the Draft Red Herring Prospectus. The information contained in the Draft Red Herring Prospectus may not be updated since its original publication date and may not reflect the latest updates. The Company and its affiliates will not be responsible for any loss to any person or entity caused by any shortcoming, defect or inaccuracy which may have inadvertently or otherwise crept into the website. Neither the Company, any of its affiliates nor their directors, officers and employees will be liable or have any responsibility of any kind for any loss or damage that you incur in the event of any failure or disruption of this website, or resulting from the act or omission of any other party involved in making this website or the data contained therein available to you, or from any other cause relating to your access to, inability to access, or use of the website or these materials.

If you are not permitted to view the materials on this website or are in any doubt as to whether you are permitted to view these materials, please exit this webpage.

To access this information, you must confirm by pressing on the button marked "I Confirm" that, at the time of access you are located and resident in India. If you cannot make this confirmation, you must press the button marked "I Do Not Confirm".

The documentation contained in these pages is posted solely to comply with Indian legal and regulatory requirements. Making the information contained herein available in electronic format does not constitute an offer to sell, the solicitation of an offer to buy, or a recommendation to buy or sell securities of the Company in the United States or in any other jurisdiction, including without limitation, India.

Current step:Step 1
Step 2
Go to Top